Literature DB >> 17851228

Mitral valvular interstitial cells demonstrate regional, adhesional, and synthetic heterogeneity.

Tracy L Blevins1, Sherket B Peterson, Elaine L Lee, Annie M Bailey, Jonathan D Frederick, Thanh N Huynh, Vishal Gupta, K Jane Grande-Allen.   

Abstract

BACKGROUND/AIMS: Because various regions of the mitral valve contain distinctive extracellular matrix enabling the tissues to withstand diverse mechanical environments, we investigated phenotype and matrix production of porcine valvular interstitial cells (VICs) from different regions.
METHODS: VICswere isolated from the chordae (MCh), the center of the anterior leaflet (AlCtr), and the posterior leaflet free edge (PlFree), then assayed for metabolic, growth, and adhesion rates; collagen and glycosaminoglycan (GAG) production, and phenotype using biochemical assays, flow cytometry, and immunocytochemistry.
RESULTS: The AlCtr VICs exhibited the fastest metabolism but slowest growth. PlFree cells grew the fastest, but demonstrated the least smooth muscle alpha-actin, vimentin, and internal complexity. AlCtr VICs secreted less collagen into the culture medium but more 4-sulfated GAGs than other cells. Adhesion-based separation resulted in altered secretion of sulfated GAGs by MCh and AlCtr cells but not by the PlFree cells.
CONCLUSIONS: VICs isolated from various regions of the mitral valve demonstrate phenotypic differences in culture, corresponding to the ability of the mitral valve to accommodate the physical stresses or altered hemodynamics that occur with injury or disease. Further understanding of VIC and valve mechanobiology could lead to novel medical or tissue engineering approaches to treat valve diseases. Copyright 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17851228      PMCID: PMC3513383          DOI: 10.1159/000108582

Source DB:  PubMed          Journal:  Cells Tissues Organs        ISSN: 1422-6405            Impact factor:   2.481


  37 in total

1.  Stress/strain characteristics of porcine mitral valve tissue: parallel versus perpendicular collagen orientation.

Authors:  K S Kunzelman; R P Cochran
Journal:  J Card Surg       Date:  1992-03       Impact factor: 1.620

2.  The effect of centrifugal force on glycosaminoglycan production by aortic smooth muscle cells in culture.

Authors:  M J Merrilees; M A Merrilees; P S Birnbaum; P J Scott; M H Flint
Journal:  Atherosclerosis       Date:  1977-07       Impact factor: 5.162

3.  Porcine mitral valve interstitial cells in culture.

Authors:  W Lester; A Rosenthal; B Granton; A I Gotlieb
Journal:  Lab Invest       Date:  1988-11       Impact factor: 5.662

4.  Finite element analysis of the mitral valve.

Authors:  K S Kunzelman; R P Cochran; C Chuong; W S Ring; E D Verrier; R D Eberhart
Journal:  J Heart Valve Dis       Date:  1993-05

5.  Differential collagen distribution in the mitral valve and its influence on biomechanical behaviour.

Authors:  K S Kunzelman; R P Cochran; S S Murphree; W S Ring; E D Verrier; R C Eberhart
Journal:  J Heart Valve Dis       Date:  1993-03

6.  Dual structural and functional phenotypes of the porcine aortic valve interstitial population: characteristics of the leaflet myofibroblast.

Authors:  R H Messier; B L Bass; H M Aly; J L Jones; P W Domkowski; R B Wallace; R A Hopkins
Journal:  J Surg Res       Date:  1994-07       Impact factor: 2.192

7.  Dynamic and reversible changes of interstitial cell phenotype during remodeling of cardiac valves.

Authors:  Elena Rabkin-Aikawa; Mark Farber; Masanori Aikawa; Frederick J Schoen
Journal:  J Heart Valve Dis       Date:  2004-09

8.  Porcine aortic valve interstitial cells in three-dimensional culture: comparison of phenotype with aortic smooth muscle cells.

Authors:  Jonathan T Butcher; Robert M Nerem
Journal:  J Heart Valve Dis       Date:  2004-05

9.  Biochemical characterization of individual normal, floppy and rheumatic human mitral valves.

Authors:  Y Lis; M C Burleigh; D J Parker; A H Child; J Hogg; M J Davies
Journal:  Biochem J       Date:  1987-06-15       Impact factor: 3.857

10.  Valvular myofibroblast activation by transforming growth factor-beta: implications for pathological extracellular matrix remodeling in heart valve disease.

Authors:  Gennyne A Walker; Kristyn S Masters; Darshita N Shah; Kristi S Anseth; Leslie A Leinwand
Journal:  Circ Res       Date:  2004-06-24       Impact factor: 17.367

View more
  6 in total

Review 1.  Differentiating the aging of the mitral valve from human and canine myxomatous degeneration.

Authors:  Patrick S Connell; Richard I Han; K Jane Grande-Allen
Journal:  J Vet Cardiol       Date:  2012-02-24       Impact factor: 1.701

Review 2.  The heterogeneous biomechanics and mechanobiology of the mitral valve: implications for tissue engineering.

Authors:  K Jane Grande-Allen; Jun Liao
Journal:  Curr Cardiol Rep       Date:  2011-04       Impact factor: 2.931

Review 3.  Mechanisms of aortic valve calcification: the LDL-density-radius theory: a translation from cell signaling to physiology.

Authors:  Nalini M Rajamannan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-10-23       Impact factor: 4.733

4.  Effect of cyclic mechanical strain on glycosaminoglycan and proteoglycan synthesis by heart valve cells.

Authors:  Vishal Gupta; Hubert Tseng; Brian D Lawrence; K Jane Grande-Allen
Journal:  Acta Biomater       Date:  2008-10-26       Impact factor: 8.947

5.  Contribution of Extra-Cardiac Cells in Murine Heart Valves is Age-Dependent.

Authors:  Lindsey J Anstine; Tori E Horne; Edwin M Horwitz; Joy Lincoln
Journal:  J Am Heart Assoc       Date:  2017-10-20       Impact factor: 5.501

6.  Identification of CD34+/PGDFRα+ Valve Interstitial Cells (VICs) in Human Aortic Valves: Association of Their Abundance, Morphology and Spatial Organization with Early Calcific Remodeling.

Authors:  Grzegorz J Lis; Andrzej Dubrowski; Maciej Lis; Bernard Solewski; Karolina Witkowska; Veronika Aleksandrovych; Ewa Jasek-Gajda; Mateusz K Hołda; Krzysztof Gil; Jan A Litwin
Journal:  Int J Mol Sci       Date:  2020-08-31       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.